However, the current rates of SCN2A mutations in both ASD and other neurodevelopmental disorder populations are likely underestimated, and the incidence is expected to increase significantly as genetic testing for these patients becomes more widespread. Here, SCN2A is linked to neurodevelopmental disorder.